Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Genetically diverse Plasmodium falciparum Southern Africa isolates provides insights into antimalarial drug sensitivity and gametocyte biology

Thesis (Ph.D (Biochemistry))--University of Pretoria, 2024.

Saved in:
Bibliographic Details
Other Authors: Birkholtz, Lyn-Marie
Format: Thesis
Language:English
Published: University of Pretoria 2025
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867613595767930880
access_status_str Open Access
author2 Birkholtz, Lyn-Marie
author_browse Birkholtz, Lyn-Marie
author_facet Birkholtz, Lyn-Marie
collection Thesis
dc_rights_str_mv © 2023 University of Pretoria. All rights reserved. The copyright in this work vests in the University of Pretoria. No part of this work may be reproduced or transmitted in any form or by any means, without the prior written permission of the University of Pretoria.
description Thesis (Ph.D (Biochemistry))--University of Pretoria, 2024.
format Thesis
id oai:repository.up.ac.za:2263/100690
institution University of Pretoria (South Africa)
language English
last_indexed 2026-06-10T12:38:39.160Z
license_str Other — see source repository
provenance_str_mv Harvested via OAI-PMH from UPSpace — University of Pretoria Institutional Repository
publishDate 2025
publishDateRange 2025
publishDateSort 2025
publisher University of Pretoria
publisherStr University of Pretoria
record_format dspace
source_str UPSpace — University of Pretoria Institutional Repository
spelling oai:repository.up.ac.za:2263/100690 Genetically diverse Plasmodium falciparum Southern Africa isolates provides insights into antimalarial drug sensitivity and gametocyte biology Birkholtz, Lyn-Marie u14006325@tuks.co.za Van der Watt, Mariëtte Greyling, Nicola UCTD Sustainable Development Goals (SDGs) Plasmodium falciparum Clinical isolates Genetic diversity Gametocytes Malaria Thesis (Ph.D (Biochemistry))--University of Pretoria, 2024. Malaria elimination requires interventions able to target both the asexual blood stage (ABS) parasites and transmissible gametocyte stages of Plasmodium falciparum. Lead antimalarial candidates are evaluated against clinical isolates to address key concerns regarding efficacy and to confirm that the current, circulating parasites from endemic regions lack resistance against these candidates. While this has largely been performed on ABS parasites, limited data are available on the transmission-blocking efficacy of compounds with multistage activity. Here, we evaluated the efficacy of lead antimalarial candidates against both ABS parasites and late-stage gametocytes side-by-side, against clinical P. falciparum isolates from southern Africa. We additionally correlated drug efficacy to the genetic diversity of the clinical isolates as determined with a panel of well-characterized, genome-spanning microsatellite markers. Our data indicate varying sensitivities of the isolates to key antimalarial candidates, both for ABS parasites and gametocyte stages. While ABS parasites were efficiently killed, irrespective of genetic complexity, antimalarial candidates lost some gametocytocidal efficacy when the gametocytes originated from genetically complex, multiple-clone infections. This suggests a fitness benefit to multiclone isolates to sustain transmission and reduce drug susceptibility. In conclusion, this is the first study to investigate the efficacy of antimalarial candidates on both ABS parasites and gametocytes from P. falciparum clinical isolates where the influence of parasite genetic complexity is highlighted, ultimately aiding the malaria elimination agenda. National Research Foundation (NRF) Biochemistry, Genetics and Microbiology (BGM) Ph.D (Biochemistry) Unrestricted Natural and Agricultural Sciences SDG-03: Good health and well-being 2025-02-11T10:52:06Z 2025-02-11T10:52:06Z 2024-10 Thesis Greyling N, van der Watt M, Gwarinda H, van Heerden A, Greenhouse B, Leroy D, Niemand J, Birkholtz L-M. Genetic complexity alters drug susceptibility of asexual and gametocyte stages of Plasmodium falciparum to antimalarial candidates. Antimicrob Agents Chemother. 2024 Mar 6;68(3):e0129123. doi: 10.1128/aac.01291-23. Epub 2024 Jan 23. PMID: 38259087; PMCID: PMC10916389. 10.1128/aac.01291-23 A2025 http://hdl.handle.net/2263/100690 en © 2023 University of Pretoria. All rights reserved. The copyright in this work vests in the University of Pretoria. No part of this work may be reproduced or transmitted in any form or by any means, without the prior written permission of the University of Pretoria. application/pdf University of Pretoria
spellingShingle UCTD
Sustainable Development Goals (SDGs)
Plasmodium falciparum
Clinical isolates
Genetic diversity
Gametocytes
Malaria
Genetically diverse Plasmodium falciparum Southern Africa isolates provides insights into antimalarial drug sensitivity and gametocyte biology
title Genetically diverse Plasmodium falciparum Southern Africa isolates provides insights into antimalarial drug sensitivity and gametocyte biology
title_full Genetically diverse Plasmodium falciparum Southern Africa isolates provides insights into antimalarial drug sensitivity and gametocyte biology
title_fullStr Genetically diverse Plasmodium falciparum Southern Africa isolates provides insights into antimalarial drug sensitivity and gametocyte biology
title_full_unstemmed Genetically diverse Plasmodium falciparum Southern Africa isolates provides insights into antimalarial drug sensitivity and gametocyte biology
title_short Genetically diverse Plasmodium falciparum Southern Africa isolates provides insights into antimalarial drug sensitivity and gametocyte biology
title_sort genetically diverse plasmodium falciparum southern africa isolates provides insights into antimalarial drug sensitivity and gametocyte biology
topic UCTD
Sustainable Development Goals (SDGs)
Plasmodium falciparum
Clinical isolates
Genetic diversity
Gametocytes
Malaria
url http://hdl.handle.net/2263/100690